Impact of Homoarginine on Myocardial Function and Remodeling in a Rat Model of Chronic Renal Failure.

Vitali KochChristophe WeberJohannes H RiffelKristina BuchnerSebastian J BussSelina HeinDerliz MerelesMarco HagenmuellerChristian ErbelWinfried MärzChristian BoozMoritz H AlbrechtThomas J VoglNorbert FreyStefan E HardtMarco Ochs

Published in: Journal of cardiovascular pharmacology and therapeutics (2022)

Dietary HA supplementation appears to have the potential of preventing cardiac remodeling and improving heart function in the setting of chronic kidney disease. Our findings shed new light on HA as a possible new therapeutic agent for patients at high cardiovascular risk.

Keyphrases

chronic kidney disease
left ventricular
end stage renal disease
heart failure
atrial fibrillation
peritoneal dialysis